ZURICH--(BUSINESS WIRE)--AL-S Pharma AG, a clinical-stage biotechnology company discovering and developing human antibodies that target misfolded proteins implicated in amyotrophic lateral sclerosis ...

Preparations underway to advance AP-101 into confirmatory Phase 3 clinical trial with initiation aimed for late 2026 ZURICH, March 19, 2026--(BUSINESS WIRE)--AL-S Pharma AG, a clinical-stage ...

Fishing duo Cole & Jay demonstrate the traditional and highly effective art of setting limblines to target heavyweight river catfish. 'Very dangerous': Ex-general sounds alarm after Hegseth fires ...

The Plain Dealer, Cleveland’s largest newspaper, has begun to feature a new byline. On recent articles about an ice carving festival, a medical research discovery and a roaming pack of chicken-slaying ...

CALGARY, Alberta, Feb. 04, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (XRTX) (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company ...

My friend recently attended a funeral, and midway through the eulogy, he became convinced that it had been written by AI. There was the telltale proliferation of abstract nouns, a surfeit of ...

Companies in the 8(a) small business contracting program are facing unprecedented pressure as the Trump administration paints it as rife with corruption and a bastion of illegal diversity, equity, and ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. The Trump administration is planning to use artificial ...

The Trump administration is planning to use artificial intelligence to write federal transportation regulations, according to U.S. Department of Transportation records and interviews with six agency ...

On Thursday, OpenAI announced its investment in neurotech startup Merge Labs, cofounded by its CEO, billionaire Sam Altman. OpenAI will collaborate with the new venture to develop technology to link ...